Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs WellMedRx

Alan Meds
Graded #98

Higher grade

vs+16.599999999999994
WellMedRx
Graded #456

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 54.5/100.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +27
72
45
Dose & formulationAlan Meds +35
75
40
Clinical oversightAlan Meds +9
82
73
Labs & monitoringWellMedRx +7
53
60
FulfillmentAlan Meds +18
78
60
Contract termsEven
55
55
Alan Meds · left barWellMedRx · right bar

The numbers

MetricAlan MedsWellMedRx
WeighScore71.1/10054.5/100
GradeCC
Scorecard rank#98#456
Semaglutide$158/mo (compounded)Not disclosed
Tirzepatide$295/mo (compounded)Not disclosed
Coverage46 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Alan Meds

Graded #98 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
WellMedRx

Graded #456 · C

Strengths

  • Named licensed pharmacy partner (Mycelium Pharmacy)
  • Clinical care delivered through OpenLoop Health, an established clinician network
  • Multi-product platform — one account covers weight loss, TRT, hair, and sexual health
  • HIPAA-compliant badge on the home page

Where it loses points

  • Monthly pricing not shown until after intake
  • State coverage not disclosed — only 'a licensed professional in your state'
  • No LegitScript registration visible on the home page
  • No NABP .pharmacy seal
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard